Desonide
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
| Image:Desonide.png | |
| Desonide
| |
| Systematic (IUPAC) name | |
| (11β,16α)-11,21-Dihydroxy-16,17-[(1-methylethylidene)bis(oxy)]-pregna-1,4-diene-3,20-dione | |
| Identifiers | |
| CAS number | |
| ATC code | S01 |
| PubChem | |
| Chemical data | |
| Formula | C24H32O6 |
| Mol. mass | 416.507 |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Desonide is the generic name of a low potency topical corticosteroid that has been available since the 1970s. It is primarily used to treat atopic dermatitis (eczema), seborrheic dermatitis, and contact dermatitis in both adults and children and has a fairly good safety profile and is available as a cream, ointment, lotion, and, since, September 19, 2006, as a foam under the tradename Verdeso Foam.
External links
